The JI Acurri Cytometers
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     
 


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Jo, E. J.
Right arrow Articles by Bae, Y.-S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Jo, E. J.
Right arrow Articles by Bae, Y.-S.
The Journal of Immunology, 2004, 173: 6433-6439.
Copyright © 2004 by The American Association of Immunologists

Group IB Secretory Phospholipase A2 Stimulates CXC Chemokine Ligand 8 Production via ERK and NF-{kappa}B in Human Neutrophils1

Eun Jin Jo2,*,{dagger}, Ha-Young Lee2,*,{dagger}, Youl-Nam Lee*, Jung Im Kim*,{dagger}, Hyun-Kyu Kang*, Dae-Won Park{ddagger}, Suk-Hwan Baek{ddagger}, Jong-Young Kwak*,{dagger} and Yoe-Sik Bae3,*,{dagger}

* Medical Research Center for Cancer Molecular Therapy and {dagger} Department of Biochemistry, College of Medicine, Dong-A University, Busan, Korea; and {ddagger} Department of Biochemistry and Molecular Biology, College of Medicine, Yeungnam University, Daegu, Korea

Although the level of group IB secretory phospholipase A2 (sPLA2-IB) has been reported to be up-regulated during inflammatory response, the role of sPLA2-IB on the regulation of inflammation and immune responses has not been fully elucidated. In this study, we found that sPLA2-IB stimulates the expression and secretion of CXCL8 without affecting other proinflammatory cytokines, such as IL-1{beta} or TNF {alpha} in human neutrophils. The induction of CXCL8 secretion by sPLA2-IB occurs at both the transcription and translational levels and correlates with activation of NF-{kappa}B. Moreover, the NF-{kappa}B inhibitors pyrrolidinedithiocarbamate, dexamethasone, or sulfasalazine were found to prevent CXCL8 production by sPLA2-IB in human neutrophils. In addition, the signaling events induced by sPLA2-IB included activation of the MAPK ERK and an increase in intracellular Ca2+, which are both required for CXCL8 production. The exogenous addition of sPLA2-IB did not induce arachidonic acid release from human neutrophils, and the inactivation of sPLA2-IB by EGTA did not affect CXCL8 production by sPLA2-IB in human neutrophils. Taken together, we suggest that sPLA2-IB plays a role in the modulation of inflammatory and immune responses via the sPLA2 receptor, by inducing CXCL8 in human neutrophils.




This article has been cited by other articles:


Home page
ThoraxHome page
N L A Misso, N Petrovic, C Grove, A Celenza, J Brooks-Wildhaber, and P J Thompson
Plasma phospholipase A2 activity in patients with asthma: association with body mass index and cholesterol concentration
Thorax, January 1, 2008; 63(1): 21 - 26.
[Abstract] [Full Text] [PDF]


Home page
Mol. Pharmacol.Home page
H. Y. Lee, M.-K. Kim, K. S. Park, E. H. Shin, S. H. Jo, S. D. Kim, E. J. Jo, Y.-N. Lee, C. Lee, S.-H. Baek, et al.
Serum Amyloid A Induces Contrary Immune Responses via Formyl Peptide Receptor-Like 1 in Human Monocytes
Mol. Pharmacol., July 1, 2006; 70(1): 241 - 248.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
D. Martinez, M. Vermeulen, A. Trevani, A. Ceballos, J. Sabatte, R. Gamberale, M. E. Alvarez, G. Salamone, T. Tanos, O. A. Coso, et al.
Extracellular Acidosis Induces Neutrophil Activation by a Mechanism Dependent on Activation of Phosphatidylinositol 3-Kinase/Akt and ERK Pathways
J. Immunol., January 15, 2006; 176(2): 1163 - 1171.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
This Website Copyright © 2004 by The American Association of Immunologists, Inc. All rights reserved.
All Contents Copyright © 2004 by The American Association of Immunologists, Inc. All rights reserved.